This report contains market size and forecasts of RNA-based Biopharmaceuticals in global, including the following market information:
Global RNA-based Biopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global RNA-based Biopharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five RNA-based Biopharmaceuticals companies in 2021 (%)
The global RNA-based Biopharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Therapeutics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of RNA-based Biopharmaceuticals include Pfizer, Roche, Sanofi-Aventis, Abbott Laboratories, Arrowhead Pharmaceuticals, Benitec Biopharma, Calimmune Inc, Dicerna and Gradalis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RNA-based Biopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA-based Biopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global RNA-based Biopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Therapeutics
Vaccines
Global RNA-based Biopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global RNA-based Biopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Global RNA-based Biopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global RNA-based Biopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA-based Biopharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies RNA-based Biopharmaceuticals revenues share in global market, 2021 (%)
Key companies RNA-based Biopharmaceuticals sales in global market, 2017-2022 (Estimated), (K Units)
Key companies RNA-based Biopharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals